TrianglePUBLICATIONS · 25092781
Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2014 Sep 20
- First author
- Gamis AS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Gamis AS
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Meshinchi S
- type
- Author
- name
- Sung L
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Kahwash SB
- type
- Author
- name
- Heerema-McKenney A
- type
- Author
- name
- Winter L
- type
- Author
- name
- Glick K
- type
- Author
- name
- Davies SM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Gamis AS
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Meshinchi S
- type
- Author
- name
- Sung L
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Kahwash SB
- type
- Author
- name
- Heerema-McKenney A
- type
- Author
- name
- Winter L
- type
- Author
- name
- Glick K
- type
- Author
- name
- Davies SM
- type
- Author
- bibliography ids
- nci-bib-5f62e3fb940941f23852ac15
- book metadata
- content sha256
- ba1d7a5cfde0a7d5e09b392736443579873f3c3ef7042439bca016511b01a9e4
- document type
- citation
- dois
- 10.1200/JCO.2014.55.3628
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25092781
- immutable id
- pubmed:25092781@ba1d7a5cfde0a7d5e09b392736443579873f3c3ef7042439bca016511b01a9e4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 27
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3021-32
- volume
- 32
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25092781
- provenance
- batch id
- 69903be8ceab8801c81a
- provider
- NCBI PubMed ESummary
- record sha256
- d8ee4331958c398490a8b47d3d7827c0def3d1505a000dd7e1a905403e7c3622
- response sha256
- 1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
- retrieved at
- 2026-09-09T23:47:05.208886+00:00
- publication date
- display
- 2014 Sep 20
- precision
- day
- year
- 2014
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.
Preserved source evidence · Not medical advice